| No. of cases (%) | P | ||
---|---|---|---|---|
Loci | Genes | Relapsed group | Non-relapsed group | Â |
A. Gain | ||||
1q21.3 | MLLT11 | 8 (42) | 17 (53) | NS |
1q22 | MUC1 | 12 (63) | 20 (63) | NS |
ARHGEF2 | 11 (58) | 20 (63) | NS | |
PMF1 | 10 (53) | 17 (53) | NS | |
1q23.1 | HAPLN2 | 11 (58) | 18 (56) | NS |
PRCC | 11 (58) | 19 (60) | NS | |
NTRK1 | 8 (42) | 18 (56) | NS | |
1q32.1 | PTPN7 | 11 (58) | 18 (56) | NS |
RBBP5 | 9 (47) | 19 (60) | NS | |
PCTK3 | 8 (42) | 17 (53) | NS | |
1q32.3 | ATF3 | 7 (37) | 18 (56) | NS |
1q42.11 | TP53BP2 | 8 (42) | 16 (50) | NS |
1q42.13 | ABCB10 | 8 (42) | 18 (56) | NS |
1q44 | AKT3 | 7 (37) | 16 (50) | NS |
3q29 | MUC4 | 10 (53) | 10 (31) | NS |
8q24.3 | BAI1 | 11 (58) | 17 (53) | NS |
PSCA | 10 (53) | 11 (34) | NS | |
16p13.3 | ABCA3 | 13 (68) | 19 (60) | NS |
B. Loss | ||||
16q23.1 | MAF | 10 (53) | 16 (50) | NS |